Rapidly Growing and Aggressive Cutaneous Squamous Cell Carcinomas in a Patient Treated with Ruxolitinib

por March-Rodriguez, Álvaro, Bellosillo, Beatriz, Álvarez-Larrán, Alberto, Besses, Carles, Pujol, Ramon M, Toll, Agustí
Publicado 2019

Should we move to a genomic classification of neutrophilic myeloid neoplasms?

por Carreño-Tarragona, Gonzalo, Álvarez-Larrán, Alberto, Hernández-Boluda, Juan Carlos, Ayala, Rosa, Cross, Nicholas C. P.
Publicado 2023

Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing

por Garrote, Marta, López-Guerra, Mónica, Arellano-Rodrigo, Eduardo, Rozman, María, Carbonell, Sara, Guijarro, Francesca, Santaliestra, Marta, Triguero, Ana, Colomer, Dolors, Cervantes, Francisco, Álvarez-Larrán, Alberto
Publicado 2023

P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING

por Garrote Ordeig, Marta, Lopez-Guerra, Monica, Arellano-Rodrigo, Eduardo, Rozman, Maria, Carbonell Ordeig, Sara, Guijarro, Francesca, Santaliestra Tomas, Marta, Triguero Moreno, Ana, Colomer, Dolors, Cervantes, Francisco, Alvarez Larran, Alberto
Publicado 2023

Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera

por Piris-Villaespesa, Miguel, Álvarez-Larrán, Alberto, Saez-Marín, Adolfo, Nuñez-Torrón, Claudia, Muñoz-Martin, Gloria, Sánchez, Ricardo, del Castillo, Francisco J., Villarrubia, Jesús, Lopez-Jimenez, Javier, Martinez-Lopez, Joaquin, Garcia-Gutierrez, Valentin
Publicado 2021

Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study

por Ayala, Rosa, Fernández, Rafael Alonso, García‐Gutiérrez, Valentín, Alvarez‐Larrán, Alberto, Osorio, Santiago, Sánchez‐Pina, Jose M., Carreño‐Tarragona, Gonzalo, Álvarez, Noemi, Gómez‐Casares, María Teresa, Duran, Antonia, Gorrochategi, Julian, Hernández‐Boluda, Juan Carlos, Martínez‐López, Joaquín
Publicado 2023

Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis

por García-Fortes, María, Hernández-Boluda, Juan C., Álvarez-Larrán, Alberto, Raya, José M., Angona, Anna, Estrada, Natalia, Fox, Laura, Cuevas, Beatriz, García-Hernández, María C., Gómez-Casares, María Teresa, Ferrer-Marín, Francisca, Saavedra, Silvana, Cervantes, Francisco, García-Delgado, Regina
Publicado 2022

Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea

por Alvarez-Larrán, Alberto, Díaz-González, Alvaro, Such, Esperanza, Mora, Elvira, Andrade-Campos, Marcio, García-Hernández, Carmen, Gómez-Casares, M. Teresa, García-Gutiérrez, Valentín, Carreño-Tarragona, Gonzalo, Garrote, Marta, Fernández-Ibarrondo, Lierni, Cervera, José, Bellosillo, Beatriz, Cervantes, Francisco, Hernández-Boluda, Juan Carlos
Publicado 2020

Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study

por Guglielmelli, Paola, Ghirardi, Arianna, Carobbio, Alessandra, Masciulli, Arianna, Maccari, Chiara, Mora, Barbara, Rumi, Elisa, Triguero, Ana, Finazzi, Maria Chiara, Pettersson, Helna, Paoli, Chiara, Mannelli, Francesco, Vanni, Daniele, Rambaldi, Alessandro, Passamonti, Francesco, Alvarez-Larràn, Alberto, Andreasson, Bjorn, Vannucchi, Alessandro M., Barbui, Tiziano
Publicado 2022

Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score

por Barbui, Tiziano, Ghirardi, Arianna, Carobbio, Alessandra, Masciulli, Arianna, Carioli, Greta, Rambaldi, Alessandro, Finazzi, Maria Chiara, Bellini, Marta, Rumi, Elisa, Vanni, Daniele, Borsani, Oscar, Passamonti, Francesco, Mora, Barbara, Brociner, Marco, Guglielmelli, Paola, Paoli, Chiara, Alvarez-Larran, Alberto, Triguero, Ana, Garrote, Marta, Pettersson, Helna, Andréasson, Björn, Barosi, Giovanni, Vannucchi, Alessandro Maria
Publicado 2022

An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase

por Steegmann, Juan Luis, Colomer, Dolors, Gómez-Casares, Maria-Teresa, García-Gutiérrez, Valentín, Ortí, Guillermo, Ramírez-Payer, Angel, Olavarria, Eduardo, Vall-llovera, Ferrán, Giraldo, Pilar, Conde, Eulogio, Vallansot, Rolando, López-Lorenzo, Jose Luis, Palomera, Luis, Álvarez-Larrán, Alberto, Conesa, Venancio, Bautista, Guiomar, Casas, Laura, Giles, Frank, Hochhaus, Andreas, Casado-Montero, Luis Felipe
Publicado 2017

Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chro...

por Steegmann, Juan Luis, Colomer, Dolors, Gómez-Casares, Maria-Teresa, García-Gutiérrez, Valentín, Ortí, Guillermo, Ramírez-Payer, Angel, Olavarria, Eduardo, Vall-llovera, Ferrán, Giraldo, Pilar, Conde, Eulogio, Vallansot, Rolando, López-Lorenzo, Jose Luis, Palomera, Luis, Álvarez-Larrán, Alberto, Conesa, Venancio, Bautista, Guiomar, Casas, Laura, Giles, Frank, Hochhaus, Andreas, Casado-Montero, Luis Felipe
Publicado 2017

P667: RISK OF PROGRESSION IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA PATIENTS ELIGIBLE FOR TYROSINE KINASE INHIBITOR DISCONTINUATION: FINAL ANALYSIS OF THE TFR-PRO STUDY

por Paolo Maria Zambrotta, Giovanni, Assouline, Sarit, Nicolini, Franck E., Abruzzese, Elisabetta, Pungolino, Ester, Cristina Miggiano, Maria, Elena, Chiara, Alvarez Larran, Alberto, Triguero Moreno, Ana, Iurlo, Alessandra, Bucelli, Cristina, Lunghi, Francesca, Capodanno, Isabella, Maffioli, Margherita, Galimberti, Sara, Caocci, Giovanni, Stagno, Fabio, Saussele, Susanne, Fava, Carmen, Le Coutre, Philipp, Bonifacio, Massimiliano, Guglielmana, Veronica, Colombo, Federica, Antolinni, Laura, Gambacorti-Passerini, Carlo
Publicado 2023

Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera

por Triguero, Ana, Pedraza, Alexandra, Pérez-Encinas, Manuel, Mata-Vázquez, María Isabel, Vélez, Patricia, Fox, Laura, Gómez-Calafat, Montse, García-Delgado, Regina, Gasior, Mercedes, Ferrer-Marín, Francisca, García-Gutiérrez, Valentín, Angona, Anna, Gómez-Casares, María Teresa, Cuevas, Beatriz, Martínez, Clara, Pérez, Raúl, Raya, José María, Guerrero, Lucía, Murillo, Ilda, Bellosillo, Beatriz, Hernández-Boluda, Juan Carlos, Sanz, Cristina, Álvarez-Larrán, Alberto
Publicado 2022

Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping

por Díaz-González, Álvaro, Mora, Elvira, Avetisyan, Gayane, Furió, Santiago, De la Puerta, Rosalía, Gil, José Vicente, Liquori, Alessandro, Villamón, Eva, García-Hernández, Carmen, Santiago, Marta, García-Ruiz, Cristian, Llop, Marta, Ferrer-Lores, Blanca, Barragán, Eva, García-Palomares, Silvia, Mayordomo, Empar, Luna, Irene, Vicente, Ana, Cordón, Lourdes, Senent, Leonor, Álvarez-Larrán, Alberto, Cervera, José, De la Rubia, Javier, Hernández-Boluda, Juan Carlos, Such, Esperanza
Publicado 2023

Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia

por Alvarez-Larrán, Alberto, Cuevas, Beatriz, Velez, Patricia, Noya, Soledad, Caballero-Navarro, Gonzalo, Ferrer-Marín, Francisca, Carbonell, Sara, Pérez-Encinas, Manuel, Gómez-Casares, María Teresa, Pérez-López, Raúl, Magro, Elena, Moretó, Ana, Pastor-Galán, Irene, Angona, Anna, Mata-Vázquez, María Isabel, Guerrero-Fernández, Lucía, Guerra, José María, Carreño-Tarragona, Gonzalo, Fox, Laura, Murillo, Ilda, García-Gutiérrez, Valentín, Mora, Elvira, Stuckey, Ruth, Arellano-Rodrigo, Eduardo, Hernández-Boluda, Juan Carlos, Pereira, Arturo
Publicado 2023

Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients

por Barbui, Tiziano, De Stefano, Valerio, Carobbio, Alessandra, Iurlo, Alessandra, Alvarez-Larran, Alberto, Cuevas, Beatriz, Ferrer Marín, Francisca, Vannucchi, Alessandro M., Palandri, Francesca, Harrison, Claire, Sibai, Hassan, Griesshammer, Martin, Bonifacio, Massimiliano, Elli, Elena M., Trotti, Chiara, Koschmieder, Steffen, Carli, Giuseppe, Benevolo, Giulia, Ianotto, Jean-Christophe, Goel, Swati, Falanga, Anna, Betti, Silvia, Cattaneo, Daniele, Arellano-Rodrigo, Eduardo, Mannelli, Lara, Vianelli, Nicola, Doyle, Andrew, Gupta, Vikas, Wille, Kai, Tremblay, Douglas, Mascarenhas, John
Publicado 2021

Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients

por Hernández-Boluda, Juan Carlos, Pereira, Arturo, Pastor-Galán, Irene, Alvarez-Larrán, Alberto, Savchuk, Alisa, Puerta, José Manuel, Sánchez-Pina, José María, Collado, Rosa, Díaz-González, Alvaro, Angona, Anna, Sagüés, Miguel, García-Gutiérrez, Valentín, Boqué, Concepción, Osorio, Santiago, Vallansot, Rolando, Palomera, Luis, Mendizábal, Arantxa, Casado, Luis Felipe, Pérez-Encinas, Manuel, Pérez-López, Raúl, Ferrer-Marín, Francisca, Sánchez-Guijo, Fermín, García, Carmen, Heras, Natalia de las, López-Lorenzo, José Luis, Cervantes, Francisco, Steegmann, Juan Luis
Publicado 2018

Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydro...

por Alvarez‐Larrán, Alberto, Garrote, Marta, Ferrer‐Marín, Francisca, Pérez‐Encinas, Manuel, Mata‐Vazquez, M. Isabel, Bellosillo, Beatriz, Arellano‐Rodrigo, Eduardo, Gómez, Montse, García, Regina, García‐Gutiérrez, Valentín, Gasior, Mercedes, Cuevas, Beatriz, Angona, Anna, Gómez‐Casares, María Teresa, Martínez, Clara M., Magro, Elena, Ayala, Rosa, del Orbe‐Barreto, Rafael, Pérez‐López, Raúl, Fox, Maria Laura, Raya, José‐María, Guerrero, Lucía, García‐Hernández, Carmen, Caballero, Gonzalo, Murillo, Ilda, Xicoy, Blanca, Ramírez, M. José, Carreño‐Tarragona, Gonzalo, Hernández‐Boluda, Juan Carlos, Pereira, Arturo
Publicado 2022

Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice

por Garcia-Gutiérrez, Valentín, Luna, Alejandro, Alonso-Dominguez, Juan M., Estrada, Natalia, Boque, Concepcion, Xicoy, Blanca, Giraldo, Pilar, Angona, Anna, Alvarez-Larrán, Alberto, Sanchez-Guijo, Fermin, Ramírez, María José, Mora, Elvira, Vélez, Patricia, Rosell, Ana, Colorado Araujo, Mercedes, Cuevas, Beatriz, Sagüés, Miguel, Cortes, Montserrat, Encinas, Manuel Perez, Casado Montero, Luis Felipe, Moreno Vega, Melania, Serrano, Luis, Gomez, Valle, Garcia-Hernandez, Carmen, Lakhwani, Sunil, Paz Coll, Antonio, de Paz, Raquel, Suarez-Varela, Sara, Fernandez-Ruiz, Andrés, Perez Lopez, Raul, Ortiz-Fernández, Almudena, Jiménez-Velasco, Antonio, Steegmann-Olmedillas, Juan Luis, Hernández-Boluda, Juan Carlos
Publicado 2021